Clinical trial
Effect of Botox Treatment for Neurogenic Detrusor Overactivity on the Prevention of Autonomic Dysreflexia Following Spinal Cord Injury
NCT02298660 is registered in ClinicalTrials.gov with Rick Hansen Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Botox Treatment for Neurogenic Detrusor Overactivity on the Prevention of Autonomic Dysreflexia Following Spinal Cord Injury
- Lead sponsor
- Rick Hansen Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- December 15, 2017
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.